Inbiogen Co. Ltd. (101140)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
7,100. 00
+140
+2.0115%
₩
114.33B Market Cap
- P/E Ratio
- Div Yield
6,286 Volume
- Eps
₩ 6,960
Previous Close Want to track 101140 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inbiogen Co. Ltd. (101140) Statistics
Valuation metrics
Market Cap 114.33B
Enterprise value 70.07B
Trailing P/E (ttm) -3.83
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 12.77
Price/Book (mrq) 0.49
Enterprise Value/Revenue 12.87
Enterprise Value/EBITDA 9.16
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.39K
Average volume (90 days) 26.62K
Price summary
52-Week low 5,910
52-Week high 14,300
Beta -
50-Day moving average 7,323.75
200-Day moving average 9,681.35
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 0:1
Last split Date 21 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.33%
Operating margin -0.73%
Operational effectiveness
Return on assets -0.12%
Return on equity -0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 545.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1,815.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 353.8
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 1.57%
Book value per share (mrq) 14,319.35
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
